Free Trial

Galecto (GLTO) Competitors

Galecto logo
$2.98 -0.09 (-2.78%)
Closing price 05/21/2025 03:58 PM Eastern
Extended Trading
$2.99 +0.02 (+0.50%)
As of 05/21/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GLTO vs. FLGC, BCDA, GOVX, EQ, EDSA, LPTX, MEIP, PRPH, GELS, and ME

Should you be buying Galecto stock or one of its competitors? The main competitors of Galecto include Flora Growth (FLGC), BioCardia (BCDA), GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), Leap Therapeutics (LPTX), MEI Pharma (MEIP), ProPhase Labs (PRPH), Gelteq (GELS), and 23andMe (ME). These companies are all part of the "pharmaceutical products" industry.

Galecto vs.

Galecto (NASDAQ:GLTO) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.

Galecto has higher earnings, but lower revenue than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GalectoN/AN/A-$38.35M-$15.53-0.19
Flora Growth$53.26M0.27-$57.04M-$0.98-0.64

Galecto has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. Galecto's return on equity of -76.96% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
GalectoN/A -76.96% -66.59%
Flora Growth -30.99%-268.17%-57.51%

14.2% of Galecto shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 10.8% of Galecto shares are owned by company insiders. Comparatively, 12.6% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Galecto presently has a consensus target price of $10.00, indicating a potential upside of 236.13%. Flora Growth has a consensus target price of $4.00, indicating a potential upside of 534.92%. Given Flora Growth's higher possible upside, analysts clearly believe Flora Growth is more favorable than Galecto.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Galecto
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Flora Growth
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Galecto received 17 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 60.38% of users gave Galecto an outperform vote while only 60.00% of users gave Flora Growth an outperform vote.

CompanyUnderperformOutperform
GalectoOutperform Votes
32
60.38%
Underperform Votes
21
39.62%
Flora GrowthOutperform Votes
15
60.00%
Underperform Votes
10
40.00%

In the previous week, Flora Growth had 4 more articles in the media than Galecto. MarketBeat recorded 4 mentions for Flora Growth and 0 mentions for Galecto. Galecto's average media sentiment score of 0.00 beat Flora Growth's score of -0.59 indicating that Galecto is being referred to more favorably in the media.

Company Overall Sentiment
Galecto Neutral
Flora Growth Negative

Galecto has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500.

Summary

Galecto and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks.

Get Galecto News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GLTO vs. The Competition

MetricGalectoPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3.93M$6.52B$5.37B$8.39B
Dividend YieldN/A2.65%5.22%4.10%
P/E Ratio-0.168.9226.8419.71
Price / SalesN/A253.80392.34117.39
Price / CashN/A65.8538.2534.62
Price / Book0.106.466.794.50
Net Income-$38.35M$143.98M$3.23B$248.18M
7 Day Performance2.23%2.03%1.53%0.20%
1 Month Performance11.01%4.11%10.06%12.37%
1 Year Performance-80.96%-2.87%16.72%7.04%

Galecto Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GLTO
Galecto
1.649 of 5 stars
$2.98
-2.8%
$10.00
+236.1%
-80.9%$3.93MN/A-0.1640
FLGC
Flora Growth
2.4924 of 5 stars
$0.75
+10.5%
$5.00
+566.7%
-47.5%$14.58M$59.51M-0.57280Gap Down
BCDA
BioCardia
2.5542 of 5 stars
$2.84
-0.4%
$25.00
+780.3%
-69.1%$14.47M$58,000.00-0.6840
GOVX
GeoVax Labs
2.158 of 5 stars
$0.93
-0.3%
$11.10
+1,099.9%
-39.1%$14.06M$5.59M-0.2510
EQ
Equillium
2.6304 of 5 stars
$0.39
-0.1%
$3.00
+669.2%
-74.5%$13.93M$41.10M-2.7940
EDSA
Edesa Biotech
2.8404 of 5 stars
$1.98
-3.4%
$21.00
+960.6%
-55.7%$13.91MN/A-1.0620Gap Down
LPTX
Leap Therapeutics
2.4352 of 5 stars
$0.38
+12.0%
$4.92
+1,210.8%
-85.6%$13.88MN/A-0.1940
MEIP
MEI Pharma
2.2004 of 5 stars
$2.08
+1.3%
N/A-31.1%$13.83M$65.30M-0.36100
PRPH
ProPhase Labs
1.8868 of 5 stars
$0.33
+7.9%
N/A-94.4%$13.69M$6.77M-0.26130News Coverage
Earnings Report
Gap Up
GELS
Gelteq
N/A$1.44
+5.1%
N/AN/A$13.59MN/A0.00N/AGap Up
ME
23andMe
N/A$0.50
-35.3%
N/A-95.3%$13.36M$208.78M-0.03770Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:GLTO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners